Business Context and Reporting Period
Company: Abbott Laboratories
Filing Type: Form 8-K (Current Report)
Date of Report: April 17, 2019
Reporting Period: First Quarter 2019
This filing announces the results of operations for the first quarter of 2019. The detailed financial data is contained in a press release furnished as Exhibit 99.1, which is incorporated by reference.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are located in the referenced Exhibit 99.1 (Press Release).
The company utilizes non-GAAP financial measures to assess performance, specifically:
- Net earnings from continuing operations excluding specified items.
- Exclusions for unusual or unpredictable factors such as acquisition and restructuring expenses, cost reduction charges, U.S. tax reform impacts, R&D asset acquisition costs, early debt extinguishment costs, and asset impairment charges.
- Exclusion of intangible amortization expense to align with internal management assessment.
Material Changes
The filing text does not explicitly detail material changes versus the prior comparable period. It notes that the press release (Exhibit 99.1) contains the results of operations and the specific non-GAAP adjustments used to evaluate ongoing business performance.
Guidance, Outlook, and Risks
Management Commentary: Management believes non-GAAP measures provide useful information for evaluating ongoing business performance and are used internally to monitor business units. However, the company cautions investors to consider these measures in addition to, and not as a substitute for, GAAP financial measures.
Risks and Contingencies: The filing highlights adjustments for specific risks and unusual items, including:
- Expenses associated with acquisitions and restructuring.
- Charges related to cost reduction initiatives.
- Estimated impacts of U.S. tax reform.
- Impairment of certain assets.
- Costs associated with the early extinguishment of debt.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q1 2019 revenue, net earnings, and cash flow figures.
- Compare GAAP net earnings against the non-GAAP adjusted net earnings to understand the magnitude of one-time charges and tax impacts.
- Verify the specific dollar amounts attributed to restructuring, acquisition, and tax reform adjustments.
- Check for any updated full-year guidance provided in the referenced press release.